Polypeptides and immunizing compositions containing
This disclosure provides isolated polypeptides isolatable from a Burkholderia spp., compositions that include one or more of the polypeptides, and methods for making and methods for using the polypeptides. This disclosure also provides antibody that specifically binds one or more of the polypeptides isolatable from a Burkholderia spp, compositions that include such antibody, and methods for using such antibody.
1. A composition comprising:
a first isolated polypeptide that is:
metal regulated in a Burkholderia spp., and
comprises an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, or SEQ ID NO:9;
a second isolated polypeptide having an amino acid sequence different than the amino acid sequence of the first isolated polypeptide, wherein the second isolated polypeptide is:
metal regulated in a Burkholderia spp., and
comprises an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, or SEQ ID NO:9; and
an effective amount of a pharmaceutically-acceptable adjuvant.
2. The composition of claim 1 , further comprising a third isolated polypeptide comprising an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, or SEQ ID NO:25.
3. The composition of claim 1 , further comprising a third polypeptide comprising the amino acid sequence of SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59, SEQ ID NO:60, SEQ ID NO:61, SEQ ID NO:62, SEQ ID NO:63, SEQ ID NO:64, SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, SEQ ID NO:69, SEQ ID NO:70, SEQ ID NO:71, SEQ ID NO:72, SEQ ID NO:73, SEQ ID NO:74, SEQ ID NO:75.
4. The composition of claim 1 , further comprising a third polypeptide comprising the amino acid sequence of SEQ ID NO:101, SEQ ID NO:102, SEQ ID NO:103, SEQ ID NO:104, SEQ ID NO:105, SEQ ID NO:106, SEQ ID NO:107, SEQ ID NO:108, SEQ ID NO:109, SEQ ID NO:110, SEQ ID NO:111, SEQ ID NO:112, SEQ ID NO:113, SEQ ID NO:114, SEQ ID NO:115, SEQ ID NO:116, SEQ ID NO:117, SEQ ID NO:118, SEQ ID NO:119, SEQ ID NO:120.
5. The composition of claim 1 , further comprising a third polypeptide comprising the amino acid sequence of SEQ ID NO:141, SEQ ID NO:142, SEQ ID NO:143, SEQ ID NO:144, SEQ ID NO:145, SEQ ID NO:146, SEQ ID NO:147, SEQ ID NO:148, SEQ ID NO:149, SEQ ID NO:150, SEQ ID NO:151, SEQ ID NO:152, SEQ ID NO:153, SEQ ID NO:154, SEQ ID NO:155, SEQ ID NO:156, SEQ ID NO:157, SEQ ID NO:158, SEQ ID NO:159, SEQ ID NO:160, SEQ ID NO:161, SEQ ID NO:162, SEQ ID NO:163, SEQ ID NO:164.
6. The composition of claim 1 , further comprising a third polypeptide comprising the amino acid sequence of SEQ ID NO:189, SEQ ID NO:190, SEQ ID NO:191, SEQ ID NO:192, SEQ ID NO:193, SEQ ID NO:194, SEQ ID NO:195, SEQ ID NO:196, SEQ ID NO:197, SEQ ID NO:198, SEQ ID NO:199, SEQ ID NO:200, SEQ ID NO:201, SEQ ID NO:202, SEQ ID NO:203, SEQ ID NO:204, SEQ ID NO:205, SEQ ID NO:206, SEQ ID NO:207, SEQ ID NO:208, SEQ ID NO:209, SEQ ID NO:210, SEQ ID NO:211.
7. A method comprising:
administering to a subject an amount of a composition effective to induce the subject to produce antibody that specifically binds to at least one component of the composition, wherein the composition comprises:
a first isolated polypeptide that is:
metal regulated in a Burkholderia spp., and
comprises an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, or SEQ ID NO:9;
a second isolated polypeptide having an amino acid sequence different than the amino acid sequence of the first isolated polypeptide, wherein the second isolated polypeptide is:
metal regulated in a Burkholderia spp., and
comprises an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, or SEQ ID NO:9;
and
an effective amount of a pharmaceutically-acceptable adjuvant.
8. A method for treating an infection in a subject, the method comprising:
administering an effective amount of a composition to a subject having or at risk of having an infection caused by a Burkholderia spp., wherein the composition comprises:
a first isolated polypeptide that is:
metal regulated in a Burkholderia spp., and
comprises an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, or SEQ ID NO:9;
a second isolated polypeptide having an amino acid sequence different than the amino acid sequence of the first isolated polypeptide, wherein the second isolated polypeptide is:
metal regulated in a Burkholderia spp., and
comprises an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, or SEQ ID NO:9;
and
an effective amount of a pharmaceutically-acceptable adjuvant.
9. A method for treating a symptom in a subject, the method comprising:
administering an effective amount of a composition to a subject having or at risk of having an infection caused by a Burkholderia spp., wherein the composition comprises:
a first isolated polypeptide that is:
metal regulated in a Burkholderia spp., and
comprises an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, or SEQ ID NO:9,
a second isolated polypeptide having an amino acid sequence different than the amino acid sequence of the first isolated polypeptide, wherein the second isolated polypeptide is:
metal regulated in a Burkholderia spp., and
comprises an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, or SEQ ID NO:9;
and
an effective amount of a pharmaceutically-acceptable adjuvant.
10. A method for decreasing colonization in a subject, the method comprising:
administering an effective amount of a composition to a subject colonized by a Burkholderia spp., wherein the composition comprises:
a first isolated polypeptide that is:
metal regulated in a Burkholderia spp., and
comprises an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, or SEQ ID NO:9,
a second isolated polypeptide having an amino acid sequence different than the amino acid sequence of the first isolated polypeptide, wherein the second isolated polypeptide is:
metal regulated in a Burkholderia spp., and
comprises an amino acid sequence having at least 90% sequence similarity to SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:7, or SEQ ID NO:9;
and
an effective amount of a pharmaceutically-acceptable adjuvant.